
Novel TMT returned to help the third-party e-commerce operator, with more than 25 brands in its stable, hike its 2021 funding to $317m.
The Deutsche Telekom and Sonae-backed cybersecurity services provider was valued at $4.3bn in a series F round that took its overall funding to more than $500m.
Access Biotechnology helped the small molecule drug developer increase its total funding to over $300m in a round led by BVF Partners.
SoftBank’s Vision Fund 2 supplied series E funding for the application management platform developer, valuing it above $1bn.
Tigermed and WuXi Biologics took part in the biopharmaceutical company's series D round, which will accelerate the development of its immuno-oncology drug candidates.
Existing investor Agilent helped the biomedical analysis technology developer close a series C round that pushed its overall funding past $110m.
Lilly Asia Ventures co-led a series A round for ProfoundBio that will help it develop its novel technology and targeted cancer therapeutics.
Binance Labs-backed crypto payment platform developer MobileCoin has now accumulated nearly $125m of total funding and is valued at $1bn.
Lilith Games helped artificial intelligence software developer Inspir.ai secure $46.3m while Microsoft AI spinoff Xiaoice closed its series A round at a billion-dollar valuation.
Tencent has co-led the digital banking app developer’s series D round, which boosted its overall funding to about $370m.